Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Global Hemp Group Inc C.GHG

Alternate Symbol(s):  GBHPF

Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to... see more

Recent & Breaking News (CSE:GHG)

CSE Bulletin: Suspension - Global Hemp Group Inc. (GHG)

Newsfile 2 days ago

Canadian Investment Regulatory Organization Trading Halt - GHG

Canada NewsWire 2 days ago

Shares of Global Hemp soar 81% on Serres Theriault acquisition

Jocelyn Aspa January 15, 2024

Global Hemp Group Announces Execution of Exclusive Option Agreement to Acquire Serres Theriault (2021) Inc. ("STI"), a Multi-Facetted, Vertically Integrated Cannabis Operator in New Brunswick and Announces Private Placement

Newsfile January 15, 2024

Canadian Investment Regulatory Organization Trade Resumption - GHG

Canada NewsWire January 15, 2024

Canadian Investment Regulatory Organization Trading Halt - GHG

Canada NewsWire January 15, 2024

CSE Bulletin: Expiry - Global Hemp Group Inc. 8SEP2023 Warrants (GHG.WT)

Newsfile August 31, 2023

Global Hemp Group (CSE:GHG) concludes first U.S. sublicense of Apollon Formularies IP

Maor Kagan April 28, 2023

Global Hemp Group Concludes First U.S. Sublicense Related to Its Recently Acquired Exclusive North American License of Apollon Formularies IP

Newsfile April 28, 2023

Global Hemp (CSE:GHG) makes final payment to license natural cancer treatments

Trevor Abes  April 6, 2023

Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property

Newsfile April 4, 2023

Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor

Newsfile March 30, 2023

Global Hemp Group Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at MD Anderson Cancer Center, as Its Chief Scientific Advisor

Newsfile March 22, 2023

Global Hemp Group Adds Israel, the European Union and Morocco as Exclusive Global Licenses from Apollon Formularies, PLC

Newsfile March 21, 2023

Global Hemp Group Announces Stephen D. Barnhill Jr. Has Been Appointed Interim President & CEO

Newsfile March 20, 2023

Global Hemp Group Welcomes Mathieu Couillard and the Continuing Engagement of Twilight Capital on Its Advisory Board

Newsfile February 17, 2023

Global Hemp Group Announces the Appointment of Arelio Useche and Veronique Laberge to the Company's Board of Directors

Newsfile February 14, 2023

CSE Bulletin: Reinstatement - Global Hemp Group Inc. (GHG, GHG.WT)

Newsfile February 9, 2023

IIROC Trade Resumption - GHG

Canada NewsWire February 9, 2023

CSE Bulletin: Suspensions (BLMH, EGFV, GHG, GHG.WT, GPK, LVT, PPK)

Newsfile February 6, 2023